David G Gaiero is Chief Financial Officer of Cyteir Therapeutics, Inc.. Currently has a direct ownership of 102,391 shares of CYT, which is worth approximately $308,196. The most recent transaction as insider was on Mar 04, 2024, when has been sold 2,373 shares (Common Stock) at a price of $1.69 per share, resulting in proceeds of $4,010. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 102K
0% 3M change
11.25% 12M change
Total Value Held $308,196

David G Gaiero Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 04 2024
BUY
Exercise of conversion of derivative security
$4,010 $1.69 p/Share
2,373 Added 2.27%
102,391 Common Stock
Feb 29 2024
BUY
Exercise of conversion of derivative security
$13,494 $1.69 p/Share
7,985 Added 7.39%
100,018 Common Stock
Dec 11 2023
BUY
Exercise of conversion of derivative security
$6,748 $1.69 p/Share
3,993 Added 4.16%
92,033 Common Stock
Nov 20 2023
BUY
Exercise of conversion of derivative security
$124,958 $1.69 p/Share
73,940 Added 45.65%
88,040 Common Stock
Jan 13 2023
BUY
Grant, award, or other acquisition
$7,450 $1.49 p/Share
5,000 Added 35.46%
9,100 Common Stock
Dec 20 2021
BUY
Exercise of conversion of derivative security
$6,888 $1.68 p/Share
4,100 Added 50.0%
4,100 Common Stock
DGG

David G Gaiero

Chief Financial Officer
Lexington, MA

Track Institutional and Insider Activities on CYT

Follow Cyteir Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYT shares.

Notify only if

Insider Trading

Get notified when an Cyteir Therapeutics, Inc. insider buys or sells CYT shares.

Notify only if

News

Receive news related to Cyteir Therapeutics, Inc.

Track Activities on CYT